Researchers Develop Tumor-Targeting MRI Contrast Based On Human Protein, University of Massachusetts Medical School Reveals

Published: Jul 10, 2017

A team led by Gang Han, PhD, has designed a human protein-based, tumor-targeting Magnetic Resonance Imaging (MRI) contrast that can be easily cleared by the body. The discovery holds promise for clinical application, including early stage tumor detection because of the enhanced MRI contrast, according to Dr. Han, associate professor of biochemistry & molecular pharmacology at University of Massachusetts Medical School.

Back to news